Twinbeech Capital LP Baxter International Inc Transaction History

Twinbeech Capital LP

$4.99 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$37.88 - $43.77 $117,390 - $135,643	3,099 Added 2.95%	108,249 $4.63 Million
Q4 2023 Feb 14, 2024	BUY	$31.71 - $38.95 $3.33 Million - $4.1 Million	105,150 New	105,150 $4.07 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $3.5 Million - $4.17 Million	87,532 New	87,532 $3.99 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $55.3 Million - $64.2 Million	1,112,903 New	1,112,903 $56.7 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $4.04 Million - $5.06 Million	-63,281 Reduced 19.94%	254,051 $16.3 Million
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $23.3 Million - $27.1 Million	303,380 Added 2174.46%	317,332 $24.6 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $1.04 Million - $1.22 Million	13,952 New	13,952 $1.2 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $4.27 Million - $4.84 Million	-57,852 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$80.5 - $88.01 $4.37 Million - $4.78 Million	54,335 Added 1544.92%	57,852 $4.66 Million
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $46,286 - $52,134	-606 Reduced 14.7%	3,517 $297,000
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $1.52 Million - $1.66 Million	-20,197 Reduced 83.05%	4,123 $331,000
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $1.9 Million - $2.21 Million	24,320 New	24,320 $1.96 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $790,768 - $946,389	-10,053 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $210,845 - $274,861	-2,946 Reduced 22.66%	10,053 $816,000
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $997,023 - $1.15 Million	12,999 New	12,999 $1.09 Million

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Account